RESEARCHER PROFILE
Bahil Ghanim
← Back to Karl Landsteiner University of Health Sciences
B
Karl Landsteiner University of Health Sciences
Bahil Ghanim works in Pulmonary Hypertension Research and Treatments, Occupational and environmental lung diseases, Transplantation: Methods and Outcomes, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. Recorded institutional associations include Karl Landsteiner University of Health Sciences.
97Publications
2,685Citations
33H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension
2018 · 141 citationsPrognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis
2015 · 134 citationsPrimary Lung Transplantation After Bridge With Extracorporeal Membrane Oxygenation
2012 · 132 citationsDistinct Differences in Gene Expression Patterns in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis with Pulmonary Hypertension
2014 · 126 citationsExtracorporeal membrane oxygenation support for complex tracheo-bronchial procedures†
2014 · 117 citationsEvolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies
2020 · 105 citationsCompartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients
2015 · 96 citationsTargeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension
2019 · 83 citationsSubtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy
2014 · 73 citationsComparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors
2013 · 72 citationsLoss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition
2017 · 69 citationsCirculating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
2014 · 67 citationsMeprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension
2013 · 66 citationsFibroblast Growth Factor Receptor Inhibition Is Active against Mesothelioma and Synergizes with Radio- and Chemotherapy
2014 · 66 citationsPrognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age
2013 · 66 citationsHigh‐mobility group box‐1 induces vascular remodelling processes via c‐Jun activation
2015 · 61 citationsTreprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation
2018 · 60 citationsImportance of kynurenine in pulmonary hypertension
2017 · 56 citationsLung Cancer in Never Smokers
2011 · 54 citationsPretreatment Serum C-Reactive Protein Levels Predict Benefit From Multimodality Treatment Including Radical Surgery in Malignant Pleural Mesothelioma
2012 · 48 citationsEndothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent
2014 · 48 citationsResident cell lineages are preserved in pulmonary vascular remodeling
2018 · 48 citationsNPY / Y 1 receptor‐mediated vasoconstrictory and proliferative effects in pulmonary hypertension
2014 · 47 citationsTemsirolimus Inhibits Malignant Pleural Mesothelioma Growth In Vitro and In Vivo: Synergism with Chemotherapy
2011 · 47 citationsDisconnect between Fibrotic Response and Right Ventricular Dysfunction
2018 · 46 citations
